| Medication | Indications | Comments |
|---|---|---|
| Aspirin (75 to 162 mg per day)1,2,48,49 | All patients without contraindications | Decreases rates of nonfatal MI, stroke, and cardiovascular death Use caution in patients with gastrointestinal bleeding |
| P2Y12 receptor antagonist (e.g., 12 clopidogrel [Plavix], ticagrelor [Brilinta], prasugrel [Effient])1,2,4,49 | Patients in whom aspirin is contraindicated or not tolerated Use in combination with aspirin after coronary stent placement | Approved for use in patients with acute coronary syndrome, recent MI, stroke, peripheral arterial disease, or coronary stent placement Use caution in patients with gastrointestinal bleeding |
| Protease-activated receptor-1 blocker (e.g., vorapaxar [Zontivity])50 | Patients with acute coronary syndrome | Reduces rates of cardiovascular death, MI, and post-MI stroke Increases risk of intracranial hemorrhage |